25I-NBOMe-d6
2,5-二甲氧基-4-碘苯乙胺衍生物内标物；4-碘-2,5-二甲氧基-d6-N-[(2-甲氧苯基)甲基]苯乙胺
25I-NBOMe-d6
2,5-二甲氧基-4-碘苯乙胺衍生物内标物；4-碘-2,5-二甲氧基-d6-N-[(2-甲氧苯基)甲基]苯乙胺
25I-NBOMe-d6
-
产品编号： CIR496502
-
相关CAS号：919797-19-6(内标物)
-
分子式：C18H16D6InO3
-
分子量：433.31
英文别名：
NBOMe-2C-I-d6；4-Iodo-2,5-(dimethoxy-d6)-N-[(2-methoxyphenyl)methyl]benzeneethanamine
SMILES：
C1C=CC2=C3C4=C(N2)C=CC=C4C=CC=13
参考文献：
Roth, B., et al.: Pharmacol. Ther., 79, 231 (1998), Peroutka, S., et al.: Pharmacol. Toxicol., 67, 373 (1990), Parrish, J., et al.: J. Neurochem., 95, 1575 (2005), Nichols, D., et al.: Chem. Rev., 108, 1614 (2008),
Labelled 25I-NBOMe (I496500). 25I-NBOMe is a derivative of the phenethylamine hallucinogen 2C-I (D470000), discovered in 2003. 25I-NBOMe acts as a highly potent agonist for the human 5-HT2A receptor. The drug is not active orally and must be taken buccally, sublingually or intranasally. This product can only be used for chemical research.
搜索质检报告(COA)
搜索MSDS
